There are two general methods to test for the presence of drug-resistant HIV: genotypic tests and phenotypic tests .
Genotypic Tests
Point mutations may occur in the virus of patients who take antiretroviral agents. Many of these mutations have been linked to the phenotypic expression of drug resistance. Genotypic testing detects the presence of mutations in a patient's virus population by identifying codon changes that differ from the standard, or "wild-type," genetic sequence of HIV.
Many of these companies also supply phenotypic testing. See phenotype table .
Genotypic: Kit Based (Sold by Manufacturer for Use in Independent Laboratories)
For further information about companies or collaborators, click on the company name.
Affymetrix
Product withdrawn from development
American Medical Laboratories
TRUGENE
Visible Genetics
See Visible Genetics information page
Applied Biosystems (formerly PE Biosystems)
ViroSeq HIV-1 Genotyping System
RDL, Contra Costa County Public Health Laboratory
Full sequence
FDA approved under an IDE4 in CLIA5 certified labs
Commercially
available6
No
See Contra Costa, RDL (CA only)
Applied Sciences
TRUGENE
A subsidiary of Visible Genetics
See Visible Genetics information page
Bayer Diagnostics
INNO-LiPA HIV-1 RT, INNO-LiPA Protease
Innogenetics
See Innogenetics information page
Content in development
Contra Costa County
ViroSeq
Applied Biosystems
See Applied Biosystems information page
Yes3
Gladstone-UCSF
TRUGENE
Visible Genetics
See Visible Genetics information page
Yes3
Innogenetics
INNO-LiPA HIV-1 RT, INNO-LiPA Protease
Bayer Diagnostics
Line probe assay/point mutations
FDA approved under an IDE4 in CLIA5 certified labs
Commercially
available
(through Bayer only)6
Content in development
Content in development
LA County
TRUGENE
Visible Genetics
See Visible Genetics information page
Yes3
RDL
TRUGENE
ViroSeq
Visible Genetics, Applied Biosystems
See Visible Genetics , Applied Biosystems information pages
Yes3
USC Pathology Reference Library
TRUGENE
Visible Genetics
See Visible Genetics information page
Yes3
Visible Genetics
TRUGENE HIV-1 Genotyping Kit
American Medical Laboratories, Applied Sciences, Gladstone-UCSF, LA County, RDL, USC
Full sequence
FDA approved for marketing
Commercially
available6
Yes
Yes
1
See HIVresistanceWeb article regarding regulatory status .
2
Some companies provide assistance with reimbursement. This category refers to those companies that provide some free or reduced price tests.
3
State of California only (California Department of Health, Office of AIDS HIV Resistance Testing Program)
4
IDE = Investigational Device Exemption [see http://www.fda.gov/cdrh/devadvice/ide/ ]; see Dr. Michelle Roland's article regarding regulatory status .
5
CLIA = Clinical Laboratory Improvement Amendments; see Dr. Michelle Roland's article regarding regulatory status .
6
Commercially available for research use only.
Many of these companies also supply phenotypic testing. See phenotype table .
Genotypic: Proprietary/Non-Kit-Based 7 (Performed by Individual Commercial or Academic Laboratories)
For further information about companies or collaborators, click on the company name.
ARUP Laboratory
HIV-1 Genotyping for Drug Resistance, Virtual Phenotype
Virco (VP only)
Full sequencing assay
CLIA certified5
Commercially available6
No
No
BC Centre
HIV RT and Protease Genotype, Virtual Phenotype
Virco (VP only)
See Virco information page
Chelsea & Westminster Hospital
GENChec
Virco (VP only)
See Virco information page
LabCorp
HIV GenoSure , HIV GenoSure Plus , Virtual Phenotype
Virco
Full sequencing assay
CLIA certified5
Commercially available6
No
No
Mayo Medical Laboratories
Not available/lab declines to provide information at this time.
Quest Diagnostics
HIV-1 Genotyping for Drug Resistance, Virtual Phenotype
Virco (VP only)
Full sequencing assay
CLIA certified5
Commercially available6
No
Yes 3
Specialty Laboratories
HIV-1 GenotypR Plus 2001
HIV GenotypR
None
Full sequencing assay
CLIA certified5
Commercially available6
No
Yes
SRL
See Virco information page
Virco
See Virco information page
Stanford University
HIV RT and Protease Genotype
None
Full sequencing assay
CLIA certified5
Commercially available6
No
Yes 3
Unilab
Content in development.
Virco
GENChec
ARUP VP , Gilead, LabCorpVP , QuestVP , BC Centre (Vancouver)VP , Chelsea and Westminster Hospital (London), SRL (Japan)
Full sequencing assay
CLIA certified5
Commercially available6
No
No
ViroLogic
GenSeq HIV
American Medical Laboratories, ARUP, Mayo Medical Laboratories, Quest Diagnostics, Specialty Laboratories
Full sequencing assay
CLIA certified5
Commercially available6
No
Yes 3
1
See HIVresistanceWeb article regarding regulatory status .
2
Some companies provide assistance with reimbursement. This category refers to those companies that provide some free or reduced price tests.
3
State of California only (California Department of Health, Office of AIDS HIV Resistance Testing Program)
4
IDE = Investigational Device Exemption [see http://www.fda.gov/cdrh/devadvice/ide/ ]; see Dr. Michelle Roland's article regarding regulatory status .
5
CLIA = Clinical Laboratory Improvement Amendments; see Dr. Michelle Roland's article regarding regulatory status .
6
Commercially available for research use only.
7
Proprietary/Non-kit-based assays are sometimes referred to as "home brew" assays. See the background article regarding this issue.
Copyright © 19972003, Vertibrae, Inc. and HIVresistanceWeb. All rights reserved. | Privacy Policy